Box Inc Reports Strong Q1 Earnings with Positive Guidance
Box Inc's stock fell 5.07% and hit a 5-day low amid broader market weakness, with the Nasdaq-100 down 0.23% and the S&P 500 down 0.07%.
Despite the stock decline, Box reported strong Q1 earnings with revenue of $306 million, an 11% year-over-year increase, marking its first double-digit growth in over 12 quarters. The company also raised its FY 2027 revenue guidance to approximately $1.28 billion, reflecting confidence in future growth. Additionally, Box repurchased 4.8 million shares for about $114 million, demonstrating its commitment to enhancing shareholder value.
The strong earnings report and positive guidance indicate that Box is well-positioned for future growth, despite the current stock price decline. The company's focus on AI investments and workflow automation is expected to drive further market demand.
Trade with 70% Backtested Accuracy
Analyst Views on BOX
About BOX
About the author

- Significant Revenue Growth: Box achieved $306 million in revenue for Q1, marking an 11% year-over-year increase, which is the first double-digit growth in over 12 quarters, indicating strong market demand for its intelligent workflow solutions, particularly the Enterprise Advanced suite.
- Optimistic Financial Outlook: CFO Dylan Smith indicated that Q2 revenue is expected to be around $319 million with an EPS of approximately $0.39, while raising the FY 2027 revenue guidance to about $1.28 billion, reflecting the company's confidence in future growth.
- Product Delivery and Innovation: Box successfully launched Box Agent and Box Automate in Q1, further solidifying its market position in enterprise data management and AI workflow, which is expected to drive continued customer growth and satisfaction.
- Share Buybacks and Financial Health: The company repurchased 4.8 million shares for approximately $114 million in Q1, demonstrating strong cash flow and commitment to shareholder returns, while also achieving a record free cash flow of $128 million.
- Airline Stocks Rise: Shares of airlines surged as oil prices fell nearly 4%, with United Airlines gaining 7% and Delta Air Lines up 4%, indicating potential profitability improvements for airlines amid reduced cost pressures.
- Telecom Infrastructure Surge: Dycom Industries saw a stock increase of about 30% after raising its full-year outlook, projecting contract revenue between $7.38 billion and $7.65 billion, and enhancing its data center capabilities through the acquisition of National Technology Integrators.
- Cloud Security Decline: Zscaler's shares tumbled over 30% after guiding for current-quarter revenue below analyst expectations, despite beating third-quarter adjusted earnings forecasts, reflecting market concerns about its future growth trajectory.
- Retail Stock Gains: Bath & Body Works shares rose 12% after forecasting second-quarter earnings per share between 20 to 25 cents, exceeding analyst expectations, which indicates strong consumer demand and improved profitability for the company.
- Zscaler Earnings Miss: Zscaler's revenue guidance for the current quarter is between $875 million and $878 million, falling short of the $879 million analysts expected, leading to a more than 23% drop in shares, indicating market concerns about its future growth.
- Peer Impact: Following Zscaler's disappointing results, shares of Palo Alto Networks and CrowdStrike fell by 4% and over 3%, respectively, reflecting a decline in market confidence across the cybersecurity sector.
- Bath & Body Works Strong Performance: The company reported better-than-expected first-quarter earnings and forecasted second-quarter EPS between 20 to 25 cents, exceeding the 21 cents expected by analysts, resulting in a 15% increase in shares, showcasing resilience in market demand.
- Semtech's Impressive Results: Semtech posted first-quarter adjusted earnings and revenue that surpassed estimates, with guidance for current-quarter earnings and EBITDA also exceeding analyst expectations, leading to a 7% rise in shares, highlighting its strong performance in the semiconductor market.
- Significant Revenue Growth: Box Inc reported Q1 revenue of $306 million, reflecting an 11% year-over-year increase and a 10% rise in constant currency, marking the company's first double-digit growth in over 12 quarters, indicating a strong rebound in market demand.
- Billings and Net Retention Rate Improvement: Billings totaled $255 million, up 5% year-over-year and 13% in constant currency; the net retention rate increased to 105%, up from 102% last year, demonstrating sustained customer recognition and reliance on Box's products and services.
- Free Cash Flow and Share Buyback: The company achieved free cash flow of $128 million, an 8% year-over-year increase, while repurchasing 4.8 million shares for approximately $114 million, reflecting proactive measures to enhance shareholder value.
- AI Investment and Market Expansion: Box is intensifying investments in AI and workflow automation, expected to drive future growth, while expanding partnerships with leading AI labs and system integrators to further enhance its ecosystem and market reach.
- Box Earnings Performance: Box reported adjusted earnings of $0.37 per share and revenue of $306 million in Q1, surpassing analyst expectations of $0.36 and $304 million, but guided for full-year adjusted earnings of $1.56, below the $1.63 expected, causing a 2% stock drop.
- Zscaler Revenue Guidance Cut: Zscaler shares plummeted 16% after guiding current-quarter revenue between $875 million and $878 million, missing the $879 million forecast, despite reporting fiscal Q3 adjusted earnings of $1.08 per share, exceeding the $1.01 estimate.
- Semtech Stock Surge: Semtech's stock rose 8% after posting Q1 adjusted earnings and revenue that beat estimates, with guidance for current-quarter earnings, adjusted operating margin, and EBITDA also exceeding analyst expectations, indicating strong market performance.
- Insulet Device Correction Issue: Insulet's shares fell about 9% following the announcement of a voluntary correction for specific lots of its medical devices due to manufacturing issues that could lead to insulin under-delivery, impacting the company's reputation and market confidence.











